(Q43722715)

26 November 2017

Risperidone-associated new-onset diabetes (English)

1 reference

26 November 2017

Wirshing DA

1

1 reference

26 November 2017

Pierre JM

2

1 reference

26 November 2017

Eyeler J

3

1 reference

26 November 2017

Weinbach J

4

1 reference

26 November 2017

Wirshing WC

5

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

26 November 2017

Biological Psychiatry

1 reference

26 November 2017

50

1 reference

26 November 2017

2

1 reference

26 November 2017

148-149

1 reference

Diabetic ketoacidosis associated with risperidone treatment?

26 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901087-3

Diphenylhydantoin: Its Use in Detecting Early Insulin Secretory Defects in Patients with Mild Glucose Intolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901087-3

Effect of Diphenylhydantoin on Insulin Secretion in Man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901087-3

New-onset diabetes mellitus associated with the initiation of quetiapine treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901087-3

Novel antipsychotics and new onset diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901087-3

10.1016/S0006-3223(01)01087-3

7 January 2021

Identifiers

DOI

1 reference

26 November 2017

1 reference